Phaseline

Targets › CHCHD10

CHCHD10 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial): drug programs, companies and trials

1 program from 1 company in 2 trials: 2 Phase 1; Neurology; next expected readout Apr 2027.

May be involved in the maintenance of mitochondrial organization and mitochondrial cristae structure. (UniProt, Q8WYQ3)

Open in Phaseline: the race on CHCHD10, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
n-Lorem FoundationnL-CHCHD-001
Antisense oligonucleotide targeting CHCHD10
CHCHD10Phase 1Amyotrophic Lateral SclerosisApr 2027

Conditions

Amyotrophic Lateral Sclerosis (2)

Modalities

small molecule (1)

Companies

n-Lorem Foundation (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.